Maria K Hordinsky – Projects and Grants — Experts@Minnesota

View Scopus Profile

Emailhordi001umnedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

14 Active
24 Finished

14 results

Filter

Active
Feasibility Study to Evaluate the Safety and Efficacy of Cellular Matrix??? BCT-HA Kit as a New Treatmentfor Dehydrated and Wrinkled Skin (A clinical and histological evaluation)
Hordinsky, M. K.
REGEN LAB SA
4/1/22 → 4/15/23
Project: Research project
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety ofRosnilimab (ANB030) in the Treatment of Subjects with Alopecia Areata
Hordinsky, M. K.
ANAPTYSBIO, INC
12/9/21 → 12/31/26
Project: Research project
A MULTICENTER, OPEN-LABEL, EXTENSION STUDY TO ASSESS THE LONGTERM SAFETY ANDEFFICACY OF CTP-543 IN ADULT PATIENTS WITHMODERATE TO SEVERE ALOPECIA AREATA
Hordinsky, M. K.
Concert Pharmaceuticals, Inc.
5/20/21 → 5/31/26
Project: Research project
A STUDY TO EVALUATE MAINTENANCE OF HAIR REGROWTH FOLLOWINGDOSE REDUCTION OF CTP-543 IN ADULT PATIENTS WITH MODERATE TOSEVERE ALOPECIA AREATA
Hordinsky, M. K.
Concert Pharmaceuticals, Inc.
3/1/21 → 3/30/26
Project: Research project
Measuring Alopecia Areata Patient-Reported Psychosocial Outcomes: Scale Development and Validation
Hordinsky, M. K.
PFIZER, INC.
10/7/20 → 1/31/23
Project: Research project
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 24-Week Study, with a 28-Week Open-Label Extension, to Assess the Safety and Efficacy of Etrasimod in Subjects with Moderate-to-Severe AlopeciaAreata
Hordinsky, M. K.
ARENA PHARMACEUTICALS, INC.
5/14/20 → 5/31/25
Project: Research project
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CTP-543 IN ADULT PATIENTS WITH MODERATE TO SEVERE ALOPECIA AREATA
Hordinsky, M. K.
Concert Pharmaceuticals, Inc.
5/1/20 → 7/30/25
Project: Research project
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Immune-MediatedInflammatory Skin Conditions
Hordinsky, M. K.
TARGET PHARMASOLUTIONS, INC
4/6/20 → 4/30/25
Project: Research project
A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY ANDSAFETY PROFILE OF PF-06651600 WITH A PARTIALLY BLINDED EXTENSIONPERIOD TO EVALUATE THE EFFICACY AND SAFETY OF PF-06651600 ANDPF-067008
Hordinsky, M. K.
PFIZER, INC.
6/20/19 → 6/30/24
Project: Research project
A PHASE 3 OPEN-LABEL, MULTI-CENTER, LONG-TERM STUDY INVESTIGATING THE SAFETY ANDEFFICACY OF PF-06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA
Hordinsky, M. K.
PFIZER, INC.
6/17/19 → 6/30/24
Project: Research project
Open-Label Study of ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), AlopeciaUniversalis (AU) and Alopecia Totalis (AT)
Hordinsky, M. K.
ACLARIS THERAPEUTICS, INC
1/4/19 → 1/31/24
Project: Research project
A Phase 2B/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata (AA) Subjects with 50% or Greater Scalp Hair Loss
Hordinsky, M. K.
PFIZER, INC.
10/9/18 → 10/30/23
Project: Research project
A Multicenter, Randomized, Double-Blind, PlaceboControlled, Operationally Seamless, Adaptive Phase 2/3Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Severe or Very SevereAlopecia Areata
Hordinsky, M. K.
Eli Lilly G.m.b.H.
8/6/18 → 8/30/23
Project: Research project
Mechanism of immune modulation by DPCP in alopecia
Hordinsky, M. K.
National Alopecia Areata Foundation
1/1/16 → 6/30/23
Project: Research project